- Flashpoint Therapeutics Announces Publication Demonstrating Superior Pre-Clinical Anti-Leukemia Efficacy with its Structural Nanomedicine Platform Business Wire
- Q&A: Postdoc Taokun Luo explains new nanomedicine that eradicates leukemia in mice 64…
Category: 6. Health
-
Flashpoint Therapeutics Announces Publication Demonstrating Superior Pre-Clinical Anti-Leukemia Efficacy with its Structural Nanomedicine Platform – Business Wire
-

Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
Garcia-Albea, who serves as director of the nurse practitioner (NP) training program in dermatology, assistant director of the Hair Loss Center for Excellence, and lead NP of the Hansen’s Disease Program at Lahey Clinic in Burlington,…
Continue Reading
-

High-resolution genomic and molecular characterization of vancomycin-resistant enterococci from hospitalized patients in a tertiary care center in Riyadh, Saudi Arabia
This study provides genomic and phenotypic characterization of vancomycin-resistant Enterococcus faecium (VREfm) and Enterococcus faecalis (VREfs) isolates from a tertiary care center in Riyadh, Saudi Arabia. Our findings reveal a high burden of…
Continue Reading
-

Researchers link ultraprocessed foods to precancerous polyps — Harvard Gazette
Colorectal cancer diagnoses have become increasingly common in adults 50 or younger in recent years, particularly in high-income countries like the U.S. The drivers of the trend are unclear, but a new study led by Harvard and Mass General…
Continue Reading
-

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani: Flipping the Script on De-escalation Trials in Oncology
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani/LinkedIn and Bishal Gyawali/oncologybg.com
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Associate Professor of Medical Oncology…
Continue Reading
-

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD
In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.
NEW ORLEANS, LA—Ticagrelor did not prove to be noninferior to prasugrel as part of dual antiplatelet therapy…
Continue Reading
-

With 42 news measles cases, US total tops 1,700
Photo: Sabin Vaccine Institute Eight suspected cases of viral hemorrhagic fever of unidentified cause in Ethiopia have prompted the World Health Organization (WHO) to dispatch a team of responders and deliver medical supplies to the southern…
Continue Reading
-

Infant Hydrocephalus in Sub-Saharan Africa
What started as a weeklong trip to treat pediatric epilepsy patients in Africa nearly 20 years ago has evolved into a sophisticated data collection and public health program that is providing Yale researchers with answers about the mysterious…
Continue Reading
-

Protect Yourself and Your Loved Ones During the Holidays
As the weather cools and gatherings move indoors, flu, COVID-19, and respiratory syncytial virus (RSV) are making their seasonal comeback. These illnesses send hundreds of thousands of Americans to the hospital every year, but there’s a…
Continue Reading
-

Mechanism and Data Behind Scp776, a First-in-Class IGF-1-Based Therapy for Acute Ischemic Stroke | NeurologyLive
The treatment landscape for acute ischemic stroke (AIS) has long centered on restoring blood flow through intravenous thrombolysis and mechanical thrombectomy. However, these approaches fail to address the underlying neuronal injury that occurs…
Continue Reading